Menu
GeneBe

rs2230768

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005751.5(AKAP9):c.4841G>A(p.Arg1614Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00137 in 1,613,748 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1614W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0078 ( 15 hom., cov: 31)
Exomes 𝑓: 0.00070 ( 16 hom. )

Consequence

AKAP9
NM_005751.5 missense

Scores

1
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.527
Variant links:
Genes affected
AKAP9 (HGNC:379): (A-kinase anchoring protein 9) The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. Alternate splicing of this gene results in at least two isoforms that localize to the centrosome and the Golgi apparatus, and interact with numerous signaling proteins from multiple signal transduction pathways. These signaling proteins include type II protein kinase A, serine/threonine kinase protein kinase N, protein phosphatase 1, protein phosphatase 2a, protein kinase C-epsilon and phosphodiesterase 4D3. [provided by RefSeq, Aug 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024280548).
BP6
Variant 7-92040822-G-A is Benign according to our data. Variant chr7-92040822-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 136330.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-92040822-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00778 (1182/151938) while in subpopulation AFR AF= 0.0272 (1127/41440). AF 95% confidence interval is 0.0259. There are 15 homozygotes in gnomad4. There are 516 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High AC in GnomAd at 1180 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
AKAP9NM_005751.5 linkuse as main transcriptc.4841G>A p.Arg1614Gln missense_variant 18/50 ENST00000356239.8
AKAP9NM_147185.3 linkuse as main transcriptc.4841G>A p.Arg1614Gln missense_variant 18/50

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
AKAP9ENST00000356239.8 linkuse as main transcriptc.4841G>A p.Arg1614Gln missense_variant 18/501 NM_005751.5 P4Q99996-2

Frequencies

GnomAD3 genomes
AF:
0.00777
AC:
1180
AN:
151822
Hom.:
15
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0272
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00576
GnomAD3 exomes
AF:
0.00186
AC:
467
AN:
251238
Hom.:
6
AF XY:
0.00122
AC XY:
166
AN XY:
135778
show subpopulations
Gnomad AFR exome
AF:
0.0252
Gnomad AMR exome
AF:
0.00110
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000616
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000704
AC:
1029
AN:
1461810
Hom.:
16
Cov.:
34
AF XY:
0.000611
AC XY:
444
AN XY:
727200
show subpopulations
Gnomad4 AFR exome
AF:
0.0240
Gnomad4 AMR exome
AF:
0.00110
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000406
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000459
Gnomad4 OTH exome
AF:
0.00149
GnomAD4 genome
AF:
0.00778
AC:
1182
AN:
151938
Hom.:
15
Cov.:
31
AF XY:
0.00695
AC XY:
516
AN XY:
74256
show subpopulations
Gnomad4 AFR
AF:
0.0272
Gnomad4 AMR
AF:
0.00216
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000208
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000132
Gnomad4 OTH
AF:
0.00570
Alfa
AF:
0.00131
Hom.:
4
Bravo
AF:
0.00852
ESP6500AA
AF:
0.0250
AC:
110
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00226
AC:
274
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxMay 18, 2012This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 09, 2021Variant summary: AKAP9 c.4841G>A (p.Arg1614Gln) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0019 in 251238 control chromosomes in the gnomAD database, including 6 homozygotes. The observed variant frequency is approximately 558 fold of the estimated maximal expected allele frequency for a pathogenic variant in AKAP9 causing Long QT Syndrome phenotype (3.3e-06), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.4841G>A in individuals affected with Long QT Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -
Benign, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
Long QT syndrome 11 Benign:2
Benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsJul 21, 2021- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabDec 05, 2021- -
Congenital long QT syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Long QT syndrome Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 15, 2024- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsSep 23, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.76
Cadd
Benign
18
Dann
Benign
0.92
Eigen
Benign
-0.72
Eigen_PC
Benign
-0.67
FATHMM_MKL
Benign
0.12
N
LIST_S2
Uncertain
0.88
D;D;D;D
MetaRNN
Benign
0.0024
T;T;T;T
MetaSVM
Benign
-0.89
T
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.13
N;.;.;.
REVEL
Benign
0.021
Sift
Benign
0.61
T;.;.;.
Vest4
0.10
MVP
0.17
MPC
0.066
ClinPred
0.00040
T
GERP RS
1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.023
gMVP
0.051

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2230768; hg19: chr7-91670136; API